KEEPING YOU UP TO DATEClearstate Healthcare InsightsClearstate Insights is your single source to all our latest healthcare intelligence. From recently published reports offering thought-provoking analysis, to information about new products and services, we will ensure you are always kept informed. Sign up to Clearstate’s newsletter
Highlights from the 2022 APAC surgical device market briefing Growth opportunities for surgical device companies are… General surgery | Surgical device and IVD | Asia | General Surgery | Surgical Gateway
How Vision 2030 is driving growth in Saudi Arabia’s IVD market The incidence of cardiovascular diseases (CVD) in… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Middle East & Africa | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx)
Middle East IVD market to recover to pre-pandemic growth rates from 2024 The Middle East IVD market has mostly recovered to… Centralised Diagnostics (CEDx) | Molecular Diagnostics (MDx) | Point-of-care testing (POCT) | Middle East & Africa | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx) | Point-of-care testing (POCT)
Cardiac biomarker testing market outlook in Latin America The incidence of cardiovascular diseases (CVD) in… In-vitro diagnostics | Point-of-care testing (POCT) | Americas | IVD Gateway | Point-of-care testing (POCT)
The future of point-of-care cardiac biomarker testing With longer life expectancies in APAC, there is an… In-vitro diagnostics | Point-of-care testing (POCT) | Global | IVD Gateway | Point-of-care testing (POCT) | The Gateway
Knee replacement innovations in Asia Pacific With longer life expectancies in APAC, there is an… General surgery | Surgical device and IVD | Asia | General Surgery | Surgical Gateway | The Gateway
Cardiac biomarker testing market outlook in Asia-Pacific The incidence of cardiovascular diseases (CVD) in… In-vitro diagnostics | Point-of-care testing (POCT) | Asia | IVD Gateway | Point-of-care testing (POCT)
Cancer biomarker testing to grow in Asia The cancer burden in Asia is increasing, with new cancer… Cancer diagnostics | In-vitro diagnostics | Infectious Diseases Testing Monitor | Molecular Diagnostics (MDx) | Asia | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx) | Size and Share Plus | The Gateway
Japan: The age of orthopaedic robotics surgery Japan’s ageing population is catalysing the demand for… Uncategorised | Asia | General Surgery | Robotic surgery | Surgical Gateway | The Gateway
China’s wound surgery market outlook China’s wound closure market—covering synthetic… General surgery | Surgical device and IVD | Asia | China Segmentation Surgical Devices Tracker | Surgical Gateway | Surgical Procedure Volume Segmentation | The Gateway
China’s surgical advanced energy devices market outlook: wider VBP rollout and intensifying competition China’s advanced energy device market—covering… General surgery | Surgical device and IVD | Asia | China Segmentation Surgical Devices Tracker | Surgical Gateway | The Gateway
China surgery: City and hospital trends Gain an understanding of where the opportunities and… General surgery | Surgical device and IVD | Asia | China Segmentation Surgical Devices Tracker | Surgical Gateway | Surgical Procedure Volume Segmentation | The Gateway
Sign up to our free newsletterThe latest trends and insights into the IVD and Surgical sectors, from our specialists and analysts, delivered directly to your inbox. Sign up to Clearstate’s newsletter today. Sign up now